Back to search

Alloy Therapeutics Uk Limited

11870377

active
Private Limited Company
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

UNIT 3 MCCLINTOCK BUILDING, GREAT ABINGTON, CB21 6GP
Incorporated 08/03/2019

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Logan Snyder

secretary · Since 08/03/2019

Errik Anderson

director · Since 08/03/2019

BIOTECH EXECUTIVE

AMERICAN · UNITED STATES · Age 48

Persons with Significant Control

Errik Anderson

ownership-of-shares-75-to-100-percent-as-firm
voting-rights-75-to-100-percent-as-firm
right-to-appoint-and-remove-directors-as-firm

American · United States · Age 48

44 South Main Street, 2nd Floor, Hanover, New Hampshire, 03755

Notified 08/03/2019

CompanyRankvs 659+ SIC 72110 peers
69

Financial strength87th percentile among SIC peers · 22/25
Employees87th percentile among SIC peers · 13/15
LiquidityCurrent ratio 1.4× · 12/20
Longevity7 years trading (max 15) · 7/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength22/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees13/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity12/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity7/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2024

Net Worth

£341k

Balance sheet strength

Cash

£709k

Cash in the bank

Net Current Assets

£239k

Working capital

Current Assets

£834k

Current Liabilities

£595k

Fixed Assets

£126k

Debtors

£124k

Profit After Tax

£186k

6avg. employees-1

Tax at Year End

Corp tax£40k

Balance Sheet

Assets less current liabilities£365k
Prepared with Caseware UK (AP4) 2024.0.164

EstimatesDerived

YearCurrent RatioImplied Profit
20241.40+£162k
20230.87

Derived from filed accounts. Not audited figures.